Fulton Financial Corporation Declares Common and Preferred Dividends
Fulton Financial Corporation Declares Common and Preferred Dividends
PR Newswire
LANCASTER, Pa., Sept. 17, 2024
LANCASTER, Pa., Sept. 17, 2024 /PRNewswire/ -- Fulton Financial Corporation ("Fulton") (Nasdaq: FULT) today announced that its Board of Directors (the "Board") declared a quarterly cash dividend of seventeen cents per share on its common stock, payable on October 15, 2024, to shareholders of record as of October 1, 2024.
In addition, Fulton announced that the Board declared a quarterly dividend of $12.81 per share (equivalent to $0.32025 per depositary share) on its Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A, payable on October 15, 2024, to shareholders of record as of September 30, 2024, for the period from and including July 15, 2024, to, but excluding, October 15, 2024.
Fulton, a more than $30 billion Lancaster, Pennsylvania-based financial holding company, has more than 3,500 employees and operates more than 200 financial centers in Pennsylvania, New Jersey, Maryland, Delaware and Virginia through Fulton Bank, N.A.
Additional information on Fulton can be found at investor.fultonbank.com.
Media:
Rachel Sharkey (717) 291-2831
Investors:
Matt Jozwiak (717) 327-2657
View original content to download multimedia:https://www.prnewswire.com/news-releases/fulton-financial-corporation-declares-common-and-preferred-dividends-302250928.html
SOURCE Fulton Bank, NA
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks